SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (1787)2/17/1997 7:47:00 AM
From: WWS   of 4342
 
Hi everyone: I'm still on my "let's find a benefactor" kick. We're rightly focused on AndroVir and AndroCar for the time being. But we may be missing the potential residing in the pharmacopia of TCM to which Paracelsian holds investigative rights. Look at what Pharmagenesis is doing with with Lilly to explore TCM for antifungals (see attached URL; then use your "find" feature to locate Pharmagenesis at the bottom of the text). Now why couldn't PRLN be doing this with one of the "big guys"? The fact that PRLN is NOT mining this rich potential vein of income is due to the fact that they're understaffed in management. Babish and Koch appear to be totally focused on Androvir and Androcar, our "nutraceuticals" (see the article on Celestial Seasonings in the URL for their use of the "nutraceuticals" term), and this is appropriate. But there is nothing to prevent another manager (the missing CEO?) to begin exploring possibility of one or more collaborative relationship with outsiders to explore this treasure trove. Of course, if/when the collaboration between Pharmagenesis and Lilly announces "discoveries", then someone will realize that PRLN has the same capacity as Pharmagenesis with respect to TCM and will beat a path to our door. But I say "be proactive", explore these possibilities NOW; not to do so is to waste precious resources and time.
richters.com
(P.S., yes I do realize that the EcoPharm division of Pharmagenesis is not dealing with TCM, but I still think PRLN is not taking full advantage of its TCM exploration rights).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext